Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry

J Neurosci. 1997 Nov 1;17(21):8169-77. doi: 10.1523/JNEUROSCI.17-21-08169.1997.

Abstract

Neuropeptide Y (NPY) agonists inhibit glutamate release by a presynaptic action at the CA3-CA1 synapse of rat hippocampus. We have examined the relationship between [Capre]t via presynaptic, voltage-dependent calcium channels (VDCCs), measured optically by using the fluorescent calcium indicator fura-2, and transmitter release, measured electrophysiologically. Activation of presynaptic NPY Y2 receptors reduced [Capre]t and thereby inhibited synaptic transmission. Multiple calcium channels are involved in synaptic transmission at this synapse. Activation of Y2 receptors inhibits N-type, P/Q-type, and unidentified presynaptic VDCCs. The inhibition of each of these calcium channel types contributes to the reduction of [Capre]t by Y2 receptors. Activation of adenosine receptors fully occluded the inhibition of presynaptic calcium influx by Y2 receptors but not the inhibition by GABAB receptors, suggesting a convergent action for Y2 and adenosine receptors, probably by coupling to the same G-protein.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine / pharmacology
  • Animals
  • Baclofen / pharmacology
  • Calcium / metabolism*
  • Calcium Channels / classification
  • Calcium Channels / physiology*
  • Calcium Channels, N-Type*
  • Electric Stimulation
  • GTP-Binding Proteins / physiology
  • Hippocampus / drug effects*
  • Ion Channel Gating / drug effects
  • Ion Transport / drug effects
  • Male
  • Models, Neurological
  • Nerve Tissue Proteins / drug effects*
  • Nerve Tissue Proteins / physiology
  • Neuropeptide Y / pharmacology*
  • Peptide Fragments
  • Peptide YY / pharmacology
  • Peptides / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, GABA-B / drug effects
  • Receptors, GABA-B / physiology
  • Receptors, Neuropeptide Y / drug effects*
  • Receptors, Neuropeptide Y / physiology
  • Receptors, Purinergic P1 / drug effects
  • Receptors, Purinergic P1 / physiology
  • Signal Transduction / drug effects
  • Spider Venoms / pharmacology
  • Synaptic Transmission / drug effects*
  • omega-Agatoxin IVA
  • omega-Conotoxin GVIA

Substances

  • Calcium Channels
  • Calcium Channels, N-Type
  • Nerve Tissue Proteins
  • Neuropeptide Y
  • Peptide Fragments
  • Peptides
  • Receptors, GABA-B
  • Receptors, Neuropeptide Y
  • Receptors, Purinergic P1
  • Spider Venoms
  • neuropeptide Y2 receptor
  • omega-Agatoxin IVA
  • omega-conotoxin receptor
  • voltage-dependent calcium channel (P-Q type)
  • Peptide YY
  • peptide YY (3-36)
  • omega-Conotoxin GVIA
  • GTP-Binding Proteins
  • Baclofen
  • Adenosine
  • Calcium